Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases

Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases

We present a series of twelve patients, bearing a wide range of solid malignancies, who received either PD-L1 or a combination of PD-L1 and CTLA-4 inhibitors. Following immunotherapy administration, they exhibited the clinical signs indicative of renal toxicity, including increased serum creatinine...

Full description

Bibliographic Details
Main Authors: Kostas Palamaris, Dimitrios Alexandris, Kostas Stylianou, Ioannis Giatras, Anastasios Stofas, Christina Kaitatzoglou, Magda Migkou, Dimitrios Goutas, Erasmia Psimenou, Eleni Theodoropoulou, Stamatios Theocharis, Nektarios Alevizopoulos, Efstathios Kastritis, Alexandros Gerakis, Harikleia Gakiopoulou
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Clinical Medicine
Subjects:
immunotherapy
immune checkpoint inhibitors
nephrotoxicity
tubulointerstitial nephritis
lupus-like membranous glomerulopathy
membranoproliferative glomerulonephritis
Online Access:https://www.mdpi.com/2077-0383/11/16/4786

Internet

https://www.mdpi.com/2077-0383/11/16/4786

Similar Items